Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosie Mngqibisa

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
The Lancet. Child & Adolescent Health|November 23, 2020
Oral PrEP in adolescents in sub-Saharan AfricaMoherndran Archary, Rosie Mngqibisa
Journal of the International AIDS Society|March 5, 2021
Accelerating drug discovery for pregnant and lactating women living with HIVRisa M Hoffman, Rosie Mngqibisa, Dawn Averitt, et al.
Respirology (Carlton, Vic.)|May 31, 2016
HIV and COPD: a conspiracy of risk factorsUmesh G Lalloo, Sandy Pillay, Rosie Mngqibisa, et al.
Lancet (London, England)|March 31, 2016
Tuberculosis controlCatherine Godfrey, Janet Andersen, Rosie Mngqibisa, et al.
AIDS (London, England)|October 2, 2025
Efficacy and safety of doravirine/islatravir in heavily treatment-experienced participants living with HIV-1: results from a randomized trialAndrew Carr, Rosie Mngqibisa, Ilsiyar Khaertynova, et al.
The Journal of Infectious Diseases|December 16, 2017
Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) StudyAndreas Ronit, Shweta Sharma, Jason V Baker, et al.
AIDS (London, England)|February 15, 2021
Efficacy, safety and central nervous system effects after switch from efavirenz/tenofovir/emtricitabine to doravirine/tenofovir/lamivudineMark Nelson, Alan Winston, Andrew Hill, et al.
The Pediatric Infectious Disease Journal|April 15, 2025
A Phase 3 Study of the Safety and Efficacy of Tedizolid Phosphate in Patients <12 Years of Age With Acute Bacterial Skin and Skin Structure InfectionsRosie Mngqibisa, Oleksandr Fofanov, Carlos F Grazioso, et al.
Clinical Pharmacology and Therapeutics|June 21, 2021
A Semimechanistic Pharmacokinetic Model for Depot Medroxyprogesterone Acetate and Drug-Drug Interactions With Antiretroviral and Antituberculosis TreatmentJose Francis, Rosie Mngqibisa, Helen McIlleron, et al.
AIDS Research and Therapy|December 30, 2024
Extensive cervical lesion and treatment outcomes in women with HIV/HPV co-infectionRosie Mngqibisa, Huichao Chen, Catherine Godfrey, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
The Lancet. Child & Adolescent Health|November 23, 2020
Oral PrEP in adolescents in sub-Saharan AfricaMoherndran Archary, Rosie Mngqibisa
Journal of the International AIDS Society|March 5, 2021
Accelerating drug discovery for pregnant and lactating women living with HIVRisa M Hoffman, Rosie Mngqibisa, Dawn Averitt, et al.
Respirology (Carlton, Vic.)|May 31, 2016
HIV and COPD: a conspiracy of risk factorsUmesh G Lalloo, Sandy Pillay, Rosie Mngqibisa, et al.
Lancet (London, England)|March 31, 2016
Tuberculosis controlCatherine Godfrey, Janet Andersen, Rosie Mngqibisa, et al.
AIDS (London, England)|October 2, 2025
Efficacy and safety of doravirine/islatravir in heavily treatment-experienced participants living with HIV-1: results from a randomized trialAndrew Carr, Rosie Mngqibisa, Ilsiyar Khaertynova, et al.
The Journal of Infectious Diseases|December 16, 2017
Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) StudyAndreas Ronit, Shweta Sharma, Jason V Baker, et al.
AIDS (London, England)|February 15, 2021
Efficacy, safety and central nervous system effects after switch from efavirenz/tenofovir/emtricitabine to doravirine/tenofovir/lamivudineMark Nelson, Alan Winston, Andrew Hill, et al.
The Pediatric Infectious Disease Journal|April 15, 2025
A Phase 3 Study of the Safety and Efficacy of Tedizolid Phosphate in Patients <12 Years of Age With Acute Bacterial Skin and Skin Structure InfectionsRosie Mngqibisa, Oleksandr Fofanov, Carlos F Grazioso, et al.
Clinical Pharmacology and Therapeutics|June 21, 2021
A Semimechanistic Pharmacokinetic Model for Depot Medroxyprogesterone Acetate and Drug-Drug Interactions With Antiretroviral and Antituberculosis TreatmentJose Francis, Rosie Mngqibisa, Helen McIlleron, et al.
AIDS Research and Therapy|December 30, 2024
Extensive cervical lesion and treatment outcomes in women with HIV/HPV co-infectionRosie Mngqibisa, Huichao Chen, Catherine Godfrey, et al.
Pageof 5